Utility of fluorine-18-fluorodeoxyglucose positron emission tomography in differentiated thyroid carcinoma with negative radioiodine scans and elevated serum thyroglobulin levels

This publication has 15 references indexed in Scilit:

• Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer
  European Journal of Nuclear Medicine and Molecular Imaging, 1997
• Pathological Tumor-Node-Metastasis (pTNM) Staging for Papillary and Follicular Thyroid Carcinomas: A Retrospective Analysis of 700 Patients
  Journal of Clinical Endocrinology & Metabolism, 1997
• Comparison of ¹⁸FDG-PET with ¹³¹Iodine and ^99mTc-Sestamibi Scintigraphy in Differentiated Thyroid Cancer
  Thyroid®, 1997
• PET in oncology: Will it replace the other modalities?
  Seminars in Nuclear Medicine, 1997
• ¹³¹I Therapy for Elevated Thyroglobulin Levels
  Thyroid®, 1997
• Treatment Guidelines for Patients With Thyroid Nodules and Well-Differentiated Thyroid Cancer
  Archives of internal medicine (1960), 1996
• Treating high thyroglobulin with radioiodine: a magic bullet or a shot in the dark?
  Journal of Clinical Endocrinology & Metabolism, 1995
• Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
  The American Journal of Medicine, 1994
• The role of iodine-131 and thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid carcinoma
  Cancer, 1993
• Sequential Serum Thyroglobulin Determinations,¹³¹I Scans, and¹³¹I Uptakes After Triiodothyronine Withdrawal in Patients with Thyroid Cancer*
  Journal of Clinical Endocrinology & Metabolism, 1981